Company

BriaCell Therapeutics Corp

Headquarters: West Vancouver, BC, Canada

Employees: 5

CEO: Dr. William V. Williams M.D.

TSXV: BCT -3.81%

Market Cap

C$168.7 Million

CAD as of Dec. 1, 2021

US$131.7 Million

Market Cap History

BriaCell Therapeutics Corp market capitalization over time

Evolution of BriaCell Therapeutics Corp market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of BriaCell Therapeutics Corp

Detailed Description

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

BriaCell Therapeutics Corp has the following listings and related stock indices.


Stock: TSXV: BCT wb_incandescent

Stock: NASDAQ: BCTX wb_incandescent

Details

Headquarters:

Bellevue Centre

Suite 300 235 West 15th Street

West Vancouver, BC V7T 2X1

Canada

Fax: 604 921 1898